David Russell Warnick, MD in Provo, UT - Medicare Family Practice

David Russell Warnick, MD is a medicare enrolled "Family Medicine" physician in Provo, Utah. He went to University Of Oklahoma College Of Medicine and graduated in 2012 and has 12 years of diverse experience with area of expertise as Family Practice. He is a member of the group practice Intermountain Healthcare Services, Inc and his current practice location is 475 W 940 N, Provo, Utah. You can reach out to his office (for appointments etc.) via phone at (801) 357-7930.

David Russell Warnick is licensed to practice in Utah (license number 8699745-1205) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1699035113.

Contact Information

	David Russell Warnick, MD
	475 W 940 N, Provo, UT 84604-3301
	(801) 357-7930
	(801) 357-7014

Physician's Profile

Full Name	David Russell Warnick
Gender	Male
Speciality	Family Practice
Experience	12 Years
Location	475 W 940 N, Provo, Utah
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

David Russell Warnick attended and graduated from University Of Oklahoma College Of Medicine in 2012

NPI Data:

NPI Number: 1699035113
Provider Enumeration Date: 05/17/2012
Last Update Date: 10/07/2015

Medicare PECOS Information:

PECOS PAC ID: 1254568801
Enrollment ID: I20131205001933

Medical Identifiers

Medical identifiers for David Russell Warnick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1699035113	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207Q00000X	Family Medicine	8699745-1205 (Utah)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
Heber Valley Hospital	Heber city, UT	Hospital
Park City Hospital	Park city, UT	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Intermountain Healthcare Services, Inc	1850209420	3063

News Archive

5-year-old British autistic boy dies after alternative therapy in U.S.

A 5-year-old British autistic boy has died after undergoing a controversial form of alternative therapy.

Severe combined immunodeficiency treated successfully with gene therapy

Gene therapy can offer a cure for a rare condition that causes children's immune systems to fail. In this rare condition, known as Severe Combined Immunodeficiency (SCID), inherited genetic mutations mean that babies are unable to fight off infection, severely limiting their chances of surviving more than a few years. Severe combined immunodeficiency (SCID) is a rare genetic disorder estimated to affect between 1 in 200,000 and 1 in 1,000,000 live births

Genetic study may help identify novel targets for treatment of high blood pressure

A genetic investigation of individuals in the Framingham Heart Study may prove useful to identify novel targets for the prevention or treatment of high blood pressure. The study, which takes a close look at networks of blood pressure-related genes, is published in the journal Molecular Systems Biology.

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

Vertex Pharmaceuticals Incorporated today announced a modification of its Phase 2 clinical trial evaluating 12-week, response-guided regimens of its lead investigational hepatitis C virus (HCV) protease inhibitor, telaprevir, in combination with its lead investigational HCV polymerase inhibitor, VX-222.

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

NPS Pharmaceuticals, Inc. (NASDAQ: NPSP), a global biopharmaceutical company pioneering and delivering therapies that transform the lives of patients with rare diseases worldwide, today announced that the company has initiated a global registration study of teduglutide in pediatric patients with Short Bowel Syndrome (SBS) who are dependent on parenteral support.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. David Russell Warnick allows following entities to bill medicare on his behalf.

Entity Name	Ihc Health Services Inc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303

News Archive

5-year-old British autistic boy dies after alternative therapy in U.S.

A 5-year-old British autistic boy has died after undergoing a controversial form of alternative therapy.

Severe combined immunodeficiency treated successfully with gene therapy

Genetic study may help identify novel targets for treatment of high blood pressure

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Russell Warnick is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Russell Warnick, MD 475 W 940 N, Provo, UT 84604-3301 Ph: (801) 357-7930	David Russell Warnick, MD 475 W 940 N, Provo, UT 84604-3301 Ph: (801) 357-7930

News Archive

5-year-old British autistic boy dies after alternative therapy in U.S.

A 5-year-old British autistic boy has died after undergoing a controversial form of alternative therapy.

Severe combined immunodeficiency treated successfully with gene therapy

Genetic study may help identify novel targets for treatment of high blood pressure

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Family Medicine Doctors in Provo, UT

Dr. Robert Joel Bush, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 750 N Freedom Blvd Ste 300, Provo, UT 84601 Phone: 801-852-1443
Janee Namealoha Sells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3200 N Canyon Rd Ste C, Provo, UT 84604 Phone: 385-375-8724
Dr. Marlin L Christianson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 West 940 North, Provo, UT 84604 Phone: 801-357-7930 Fax: 801-357-7014
Tyson Schwab, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 205, Provo, UT 84604 Phone: 801-357-1770
Mr. Gregory Lawrence Nielsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1750 N Wymount Terrace Dr, Provo, UT 84604 Phone: 801-422-2771 Fax: 801-422-0761
Mr. Tyler Jason Fieldsted, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 W 940 N, Provo, UT 84604 Phone: 801-357-7926 Fax: 801-357-7927
Dr. Matthew Craig Evans, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 N 300 W, #201, Provo, UT 84604 Phone: 801-581-2000

David Russell Warnick, MD - Medicare Family Practice in Provo, UT

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

5-year-old British autistic boy dies after alternative therapy in U.S.

Severe combined immunodeficiency treated successfully with gene therapy

Genetic study may help identify novel targets for treatment of high blood pressure

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Medicare Reassignments

5-year-old British autistic boy dies after alternative therapy in U.S.

Severe combined immunodeficiency treated successfully with gene therapy

Genetic study may help identify novel targets for treatment of high blood pressure

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

5-year-old British autistic boy dies after alternative therapy in U.S.

Severe combined immunodeficiency treated successfully with gene therapy

Genetic study may help identify novel targets for treatment of high blood pressure

Vertex announces modification of telaprevir and VX-222 combination Phase 2 trial for treatment of HCV

NPSP to conduct open-label study to evaluate teduglutide in pediatric patients with SBS

Family Medicine Doctors in Provo, UT